FDA NDC Directory · JSON-LD · Markdown

Duloxetine

NDC 82009-172 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Labeler / ManufacturerQuallent Pharmaceuticals Health LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA208706
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsDULOXETINE HYDROCHLORIDE (40 mg/1)
Marketing started20250701
Package count1

External sources

Source: openFDA. Public-domain (CC0).